Rosuvastatin Unknown Status Phase 2 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection

IndicationsStatusPurposePhase
Unknown StatusNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01874743Rosuvastatin to Decrease Residual Immune Activation in HIV Infection